Torem 5mg tablets

देश: यूनाइटेड किंगडम

भाषा: अंग्रेज़ी

स्रोत: MHRA (Medicines & Healthcare Products Regulatory Agency)

सक्रिय संघटक:

Torasemide

थमां उपलब्ध:

Viatris UK Healthcare Ltd

ए.टी.सी कोड:

C03CA04

INN (इंटरनेशनल नाम):

Torasemide

डोज़:

5mg

फार्मास्यूटिकल फॉर्म:

Oral tablet

प्रशासन का मार्ग:

Oral

वर्ग:

No Controlled Drug Status

प्रिस्क्रिप्शन प्रकार:

Valid as a prescribable product

उत्पाद समीक्षा:

BNF: 02020200; GTIN: 5000471005356

सूचना पत्रक

3OHDVHUHDGDOORIWKLVOHDÀHW
CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
‡
.HHSWKLVOHDIOHW

पूरा दस्तावेज़ पढ़ें

उत्पाद विशेषताएं

OBJECT 1
TOREM 5 MG TABLETS
Summary of Product Characteristics Updated 29-May-2018 | Mylan
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Torem 5mg Tablets
2. Qualitative and quantitative composition
Each tablet contains 5.0mg torasemide.
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Tablets.
White to off-white round tablets with the imprint “T 5.0“ and break
mark on one side and plain on the
other side.
4. Clinical particulars
4.1 Therapeutic indications
Essential hypertension; oedema due to congestive heart failure;
hepatic, pulmonary or renal oedema.
4.2 Posology and method of administration
_ADULTS_
_Essential hypertension:_ A dose of 2.5mg torasemide once daily is
recommended. If necessary, the dose
may be increased to 5mg once daily. Studies suggest that doses above
5mg daily will not lead to further
reduction in blood pressure. The maximum effect is exhibited after
approximately twelve weeks of
continuous treatment.
_Oedema:_ The usual